FOLH1 and metastatic neoplasm: 68Ga-PSMA-11 PET/CT detected metastatic disease (M1) in 20.4% (158/775) of patients; seminal vesicle invasion was detected in 37.9% (294/775); and pelvic lymph node involvement (N1) was detected in 43.5% (337/775).